FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 321:406-412 August 10, 1989 Number 6

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

The occurrence of ventricular premature depolarizations in survivors of myocardial infarction is a risk factor for subsequent sudden death, but whether antiarrhythmic therapy reduces the risk is not known. The Cardiac Arrhythmia Suppression Trial (CAST) is evaluating the effect of antiarrhythmic therapy (encainide, flecainide, or moricizine) in patients with asymptomatic or mildly symptomatic ventricular arrhythmia (six or more ventricular premature beats per hour) after myocardial infarction. As of March 30, 1989, 2309 patients had been recruited for the initial drug-titration phase of the study: 1727 (75 percent) had initial suppression of their arrhythmia (as assessed by Holter recording) through the use of one of the three study drugs and had been randomly assigned to receive active drug or placebo. During an average of 10 months of follow-up, the patients treated with active drug had a higher rate of death from arrhythmia than the patients assigned to placebo. Encainide and flecainide accounted for the excess of deaths from arrhythmia and nonfatal cardiac arrests (33 of 730 patients taking encainide or flecainide [4.5 percent]; 9 of 725 taking placebo [1.2 percent]; relative risk, 3.6; 95 percent confidence interval, 1.7 to 8.5). They also accounted for the higher total mortality (56 of 730 [7.7 percent] and 22 of 725 [3.0 percent], respectively; relative risk, 2.5; 95 percent confidence interval, 1.6 to 4.5). Because of these results, the part of the trial involving encainide and flecainide has been discontinued. We conclude that neither encainide nor flecainide should be used in the treatment of patients with asymptomatic or minimally symptomatic ventricular arrhythmia after myocardial infarction, even though these drugs may be effective initially in suppressing ventricular arrhythmia. Whether these results apply to other patients who might be candidates for antiarrhythmic therapy is unknown.

This article has been cited by other articles:

• Groh, W. J., Groh, M. R., Saha, C., Kincaid, J. C., Simmons, Z., Ciafaloni, E., Pourmand, R., Otten, R. F., Bhakta, D., Nair, G. V., Marashdeh, M. M., Zipes, D. P., Pascuzzi, R. M. (2008). Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1. NEJM 358: 2688-2697 [Abstract] [Full Text]  
• Lassere, M. N (2008). The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints. Stat Methods Med Res 17: 303-340 [Abstract]  
• Steg, P. G., Marre, M. (2008). Does PERISCOPE Provide a New Perspective on Diabetic Treatment?. JAMA 299: 1603-1604 [Full Text]  
• Wellens, H. J. (2008). Forty Years of Invasive Clinical Electrophysiology: 1967-2007. Circ Arrhythmia Electrophysiol 1: 49-53 [Full Text]  
• Au, D. H (2008). Use of {beta} blockers in patients with COPD. Thorax 63: 296-298 [Full Text]  
• BURASHNIKOV, A., DI DIEGO, J. M., ZYGMUNT, A. C., BELARDINELLI, L., ANTZELEVITCH, C. (2008). Atrial-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation. Ann. N. Y. Acad. Sci. 1123: 105-112 [Abstract] [Full Text]  
• Kawabata, M., Hirao, K., Higuchi, K., Sasaki, T., Furukawa, T., Okada, H., Hachiya, H., Isobe, M. (2008). Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction. Europace 10: 284-288 [Abstract] [Full Text]  
• Venetucci, L. A., Trafford, A. W., O'Neill, S. C., Eisner, D. A. (2008). The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc Res 77: 285-292 [Abstract] [Full Text]  
• Levy, J. H., Tanaka, K. A., Bailey, J. M. (2008). Cardiac Surgical Pharmacology. Card Surg Adult 3: 77-110 [Full Text]  
• Spotnitz, H. M. (2008). Surgical Implantation of Pacemakers and Automatic Defibrillators. Card Surg Adult 3: 1395-1428 [Full Text]  
• Lin, J. W., Garber, L., Qi, Y. R., Chang, M. G., Cysyk, J., Tung, L. (2008). Region of slowed conduction acts as core for spiral wave reentry in cardiac cell monolayers. Am. J. Physiol. Heart Circ. Physiol. 294: H58-H65 [Abstract] [Full Text]  
• Noujaim, S. F., Berenfeld, O., Kalifa, J., Cerrone, M., Nanthakumar, K., Atienza, F., Moreno, J., Mironov, S., Jalife, J. (2007). Universal scaling law of electrical turbulence in the mammalian heart. Proc. Natl. Acad. Sci. USA 104: 20985-20989 [Abstract] [Full Text]  
• Koistinen, J., Valtonen, M., Savola, J., Airaksinen, J. (2007). Thoracoscopic microwave ablation of atrial fibrillation. ICVTS 6: 695-698 [Abstract] [Full Text]  
• London, B., Michalec, M., Mehdi, H., Zhu, X., Kerchner, L., Sanyal, S., Viswanathan, P. C., Pfahnl, A. E., Shang, L. L., Madhusudanan, M., Baty, C. J., Lagana, S., Aleong, R., Gutmann, R., Ackerman, M. J., McNamara, D. M., Weiss, R., Dudley, S. C. Jr (2007). Mutation in Glycerol-3-Phosphate Dehydrogenase 1 Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias. Circulation 116: 2260-2268 [Abstract] [Full Text]  
• Aydin, O., Becker, R., Kraft, P., Voss, F., Koch, M., Kelemen, K., Katus, H. A., Bauer, A. (2007). Effects of protein kinase C activation on cardiac repolarization and arrhythmogenesis in Langendorff-perfused rabbit hearts. Europace 9: 1094-1098 [Abstract] [Full Text]  
• Lujan, H. L., Kramer, V. J., DiCarlo, S. E. (2007). Sex influences the susceptibility to reperfusion-induced sustained ventricular tachycardia and beta-adrenergic receptor blockade in conscious rats. Am. J. Physiol. Heart Circ. Physiol. 293: H2799-H2808 [Abstract] [Full Text]  
• Mark, D. B (2007). Percutaneous coronary revascularisation: is it ever worth what it costs?. Heart 93: 1161-1163 [Full Text]  
• Burashnikov, A., Di Diego, J. M., Zygmunt, A. C., Belardinelli, L., Antzelevitch, C. (2007). Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine. Circulation 116: 1449-1457 [Abstract] [Full Text]  
• Hohnloser, S. H., Prystowsky, E. N. (2007). CRT-D use in heart failure: too little or too much?. Eur Heart J Suppl 9: G9-G16 [Abstract] [Full Text]  
• Obuchowski, N. A., Schoenhagen, P., Modic, M. T., Meziane, M., Budd, G. T. (2007). Incidence of Advanced Symptomatic Disease as Primary Endpoint in Screening and Prevention Trials. Am. J. Roentgenol. 189: 19-23 [Abstract] [Full Text]  
• Wittes, J., Barrett-Connor, E., Braunwald, E., Chesney, M., Cohen, H. J., DeMets, D., Dunn, L., Dwyer, J., Heaney, R. P., Vogel, V., Walters, L., Yusuf, S. (2007). Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board. Clin Trials 4: 218-234 [Abstract]  
• Patel, J., Heywood, J. T. (2007). Mode of Death in Patients With Systolic Heart Failure. J CARDIOVASC PHARMACOL THER 12: 127-136 [Abstract]  
• Stokoe, K. S., Balasubramaniam, R., Goddard, C. A., Colledge, W. H., Grace, A. A., Huang, C. L.-H. (2007). Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/ murine hearts modelling the Brugada syndrome. J. Physiol. 581: 255-275 [Abstract] [Full Text]  
• Khavandi, A, Walker, P R (2007). Flecainide cardiotoxicity precipitated by electrolyte imbalance. Caution with thiazide diuretics. Emerg. Med. J. 24: e26-e26 [Abstract] [Full Text]  
• Nattel, S., Maguy, A., Le Bouter, S., Yeh, Y.-H. (2007). Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation. Physiol. Rev. 87: 425-456 [Abstract] [Full Text]  
• Bauer, A., Becker, R., Dreyhaupt, J., Voss, F., Kraft, P., Kelemen, K., Senges-Becker, J. C., Katus, H. A., Schoels, W. (2007). Role of KATP channels in repetitive induction of ventricular fibrillation. Europace 9: 154-161 [Abstract] [Full Text]  
• Jensen, G. B., Hampton, J. (2007). Early termination of drug trials. BMJ 334: 326-326 [Full Text]  
• Cooper, C. J., Murphy, T. P. (2007). The Case for Renal Artery Stenting for Treatment of Renal Artery Stenosis. Circulation 115: 263-270 [Full Text]  
• Den Ruijter, H. M., Berecki, G., Opthof, T., Verkerk, A. O., Zock, P. L., Coronel, R. (2007). Pro- and antiarrhythmic properties of a diet rich in fish oil. Cardiovasc Res 73: 316-325 [Abstract] [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]  
• Ikeda, T., Yoshino, H., Sugi, K., Tanno, K., Shimizu, H., Watanabe, J., Kasamaki, Y., Yoshida, A., Kato, T. (2006). Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients With Preserved Cardiac Function After Acute Myocardial Infarction: Results of a Collaborative Cohort Study. J Am Coll Cardiol 48: 2268-2274 [Abstract] [Full Text]  
• Finch, S. J., van Zyl, L. T. (2006). Cardioversion of Persistent Atrial Arrhythmia After Treatment With Venlafaxine in Successful Management of Major Depression and Posttraumatic Stress Disorder. Psychosomatics 47: 533-536 [Abstract] [Full Text]  
• Barzilay, J. I., Davis, B. R., Cutler, J. A., Pressel, S. L., Whelton, P. K., Basile, J., Margolis, K. L., Ong, S. T., Sadler, L. S., Summerson, J., for the ALLHAT Collaborative Research Group, (2006). Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).. Arch Intern Med 166: 2191-2201 [Abstract] [Full Text]  
• Ng, G A. (2006). Treating patients with ventricular ectopic beats.. Heart 92: 1707-1712 [Full Text]  
• Tan, B.-H., Valdivia, C. R., Song, C., Makielski, J. C. (2006). Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine. Am. J. Physiol. Heart Circ. Physiol. 291: H1822-H1828 [Abstract] [Full Text]  
• Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-e346 [Full Text]  
• Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 746-837 [Full Text]  
• Granger, C. B., McMurray, J. J.V. (2006). Using Measures of Disease Progression to Determine Therapeutic Effect: A Sirens' Song. J Am Coll Cardiol 48: 434-437 [Abstract] [Full Text]  
• Cohn, J. N. (2006). Efficacy and Safety in Clinical Trials in Cardiovascular Disease. J Am Coll Cardiol 48: 430-433 [Abstract] [Full Text]  
• Boyle, A. J., Schulman, S. P., Hare, J. M. (2006). Stem Cell Therapy for Cardiac Repair: Ready for the Next Step. Circulation 114: 339-352 [Full Text]  
• Kesselheim, A. S., Fischer, M. A., Avorn, J. (2006). The rise and fall of Natrecor for congestive heart failure: implications for drug policy.. Health Aff (Millwood) 25: 1095-1102 [Abstract] [Full Text]  
• Tardif, J.-C., Heinonen, T., Orloff, D., Libby, P. (2006). Vascular Biomarkers and Surrogates in Cardiovascular Disease. Circulation 113: 2936-2942 [Abstract] [Full Text]  
• Verkerk, A. O., van Ginneken, A. C.G., Berecki, G., den Ruijter, H. M., Schumacher, C. A., Veldkamp, M. W., Baartscheer, A., Casini, S., Opthof, T., Hovenier, R., Fiolet, J. W.T., Zock, P. L., Coronel, R. (2006). Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res 70: 509-520 [Abstract] [Full Text]  
• Weiss, J. N., Karma, A., Shiferaw, Y., Chen, P.-S., Garfinkel, A., Qu, Z. (2006). From Pulsus to Pulseless: The Saga of Cardiac Alternans. Circ. Res. 98: 1244-1253 [Abstract] [Full Text]  
• Roth-Cline, M. D. (2006). Clinical Trials in the Wake of Vioxx: Requiring Statistically Extreme Evidence of Benefit to Ensure the Safety of New Drugs. Circulation 113: 2253-2259 [Full Text]  
• Society for Clinical Trials Board of Directors, (2006). The Society for Clinical Trials opposes US legislation to permit marketing of unproven medical therapies for seriously ill patients. Clin Trials 3: 154-157  
• Enseleit, F., Duru, F. (2006). Long-term continuous external electrocardiographic recording: a review.. Europace 8: 255-266 [Abstract] [Full Text]  
• Cochrane, T. I., Truog, R. D., Mareiniss, D. P., Glick, S. M., Casarett, D., Kapo, J., Caplan, A. (2006). Appropriate use of artificial nutrition and hydration.. NEJM 354: 1320-1321 [Full Text]  
• Connolly, S. J. (2006). Use and Misuse of Surrogate Outcomes in Arrhythmia Trials. Circulation 113: 764-766 [Full Text]  
• Bunch, T. J., Ackerman, M. J. (2006). Promoting Arrhythmia Susceptibility. Circulation 113: 330-332 [Full Text]  
• Bezzina, C. R., Shimizu, W., Yang, P., Koopmann, T. T., Tanck, M. W.T., Miyamoto, Y., Kamakura, S., Roden, D. M., Wilde, A. A.M. (2006). Common Sodium Channel Promoter Haplotype in Asian Subjects Underlies Variability in Cardiac Conduction. Circulation 113: 338-344 [Abstract] [Full Text]  
• Bito, V., Dauwe, D., Verdonck, F., Mubagwa, K., Sipido, K. R. (2006). The Amiodarone Derivative KB130015 [2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran] Induces an Na+-Dependent Increase of [Ca2+] in Ventricular Myocytes. J. Pharmacol. Exp. Ther. 316: 162-168 [Abstract] [Full Text]  
• Thabut, G., Logeart, D. (2005). Thrombolysis for Pulmonary Embolism in Patients With Right Ventricular Dysfunction: Con. Arch Intern Med 165: 2200-2203 [Full Text]  
• Halpern, S. D (2005). Towards evidence based bioethics. BMJ 331: 901-903 [Full Text]  
• Singh, B. N. (2005). {beta}-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview. J CARDIOVASC PHARMACOL THER 10: S3-S14 [Abstract]  
• Qu, Z., Weiss, J. N. (2005). Effects of Na+ and K+ channel blockade on vulnerability to and termination of fibrillation in simulated normal cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 289: H1692-H1701 [Abstract] [Full Text]  
• Collette, L., Burzykowski, T., Carroll, K. J., Newling, D., Morris, T., Schroder, F. H. (2005). Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals. JCO 23: 6139-6148 [Abstract] [Full Text]  
• Verma, A., Natale, A., Padanilam, B. J., Prystowsky, E. N., Verma, A., Natale, A., Padanilam, B. J., Prystowsky, E. N. (2005). Why Atrial Fibrillation Ablation Should Be Considered First-Line Therapy for Some Patients. Circulation 112: 1214-1222 [Full Text]  
• Weiss, J. N., Qu, Z., Chen, P.-S., Lin, S.-F., Karagueuzian, H. S., Hayashi, H., Garfinkel, A., Karma, A. (2005). The Dynamics of Cardiac Fibrillation. Circulation 112: 1232-1240 [Abstract] [Full Text]  
• Jochmann, N., Stangl, K., Garbe, E., Baumann, G., Stangl, V. (2005). Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 26: 1585-1595 [Abstract] [Full Text]  
• Falk, R. H. (2005). Rate Control Is Preferable to Rhythm Control in the Majority of Patients With Atrial Fibrillation. Circulation 111: 3141-3150 [Full Text]  
• Dorn, A., Hermann, F., Ebneth, A., Bothmann, H., Trube, G., Christensen, K., Apfel, C. (2005). Evaluation of a High-Throughput Fluorescence Assay Method for hERG Potassium Channel Inhibition. J Biomol Screen 10: 339-347 [Abstract]  
• Authors/Task Force Members, , Swedberg, K., Writing Committee:, , Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Other Contributors, , Gavazzi, A., Haverich, A., Hoes, A., Jaarsma, T., Korewicki, J., Levy, S., Linde, C., Lopez-Sendon, J.-L., Nieminen, M. S., Pierard, L., Remme, W. J. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140 [Full Text]  
• Buxton, A. E., Moss, A. J., Buxton, A. E., Moss, A. J. (2005). Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator?. Circulation 111: 2537-2549 [Full Text]  
• Roose, S. P., Miyazaki, M. (2005). Pharmacologic Treatment of Depression in Patients With Heart Disease. Psychosom. Med. 67: S54-S57 [Abstract] [Full Text]  
• Takemoto, M., Yoshimura, H., Ohba, Y., Matsumoto, Y., Yamamoto, U., Mohri, M., Yamamoto, H., Origuchi, H. (2005). Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease. J Am Coll Cardiol 45: 1259-1265 [Abstract] [Full Text]  
• Schulman, J. K., Muskin, P. R., Shapiro, P. A. (2005). Psychiatry and Cardiovascular Disease. Focus 3: 208-224 [Abstract] [Full Text]  
• Gronefeld, G. C., Hohnloser, S. H., Konety, S. H., Olshansky, B., Wittkowsky, A. K., Alboni, P., Botto, G. I., Baldi, N. (2005). The "Pill-in-the-Pocket" Approach to Atrial Fibrillation. NEJM 352: 1150-1151 [Full Text]  
• Spector, P. S (2005). Diagnosis and management of sudden cardiac death. Heart 91: 408-413 [Full Text]  
• Rathore, S. S., Radford, M. J., Krumholz, H. M. (2005). Blood Transfusion in Patients With Acute Coronary Syndrome. JAMA 293: 673-673 [Full Text]  
• Geelen, A., Brouwer, I. A, Schouten, E. G, Maan, A. C, Katan, M. B, Zock, P. L (2005). Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am. J. Clin. Nutr. 81: 416-420 [Abstract] [Full Text]  
• Roden, D. M. (2005). An Underrecognized Challenge in Evaluating Postmarketing Drug Safety. Circulation 111: 246-248 [Full Text]  
• Lin, C., Ke, X., Cvetanovic, I., Ranade, V., Somberg, J. (2005). The Influence of Extracellular Acidosis on the Effect of IKr Blockers. J CARDIOVASC PHARMACOL THER 10: 67-76 [Abstract]  
• Shah, S U, Iqbal, Z, White, A, White, S (2005). Heart and mind: (2) psychotropic and cardiovascular therapeutics. Postgrad. Med. J. 81: 33-40 [Abstract] [Full Text]  
• Zimetbaum, P., Josephson, M. E. (2004). Is There a Role for Maintaining Sinus Rhythm in Patients with Atrial Fibrillation?. ANN INTERN MED 141: 720-726 [Abstract] [Full Text]  
• Ramos, E., O'Leary, M. E (2004). State-dependent trapping of flecainide in the cardiac sodium channel. J. Physiol. 560: 37-49 [Abstract] [Full Text]  
• Wellens, H. J.J. (2004). Cardiac arrhythmias: The quest for a cure: A historical perspective. J Am Coll Cardiol 44: 1155-1163 [Abstract] [Full Text]  
• Kaufman, E. S., Zimmermann, P. A., Wang, T., Dennish, G. W. III, Barrell, P. D., Chandler, M. L., Greene, H. L., AFFIRM Investigators, (2004). Risk of proarrhythmic events in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study: A multivariate analysis. J Am Coll Cardiol 44: 1276-1282 [Abstract] [Full Text]  
• Legro, R. S., Myers, E., for the Reproductive Medicine Network, (2004). Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?. Hum Reprod 19: 1697-1704 [Abstract] [Full Text]  
• Cuervo, L. G., Aronson, J. K (2004). The road to health care. BMJ 329: 1-2 [Full Text]  
• Wyse, D. G., Gersh, B. J. (2004). Atrial Fibrillation: A Perspective: Thinking Inside and Outside the Box. Circulation 109: 3089-3095 [Full Text]  
• Zhang, Y., Thamer, M., Stefanik, K., Cotter, D. J. (2004). Does dose matter?. Nephrol Dial Transplant 19: 1658-1658 [Full Text]  
• Molenberghs, G., Burzykowski, T., Alonso, A., Buyse, M. (2004). A perspective on surrogate endpoints in controlled clinical trials. Stat Methods Med Res 13: 177-206 [Abstract]  
• Lader, E. W., Cannon, C. P., Ohman, E. M., Newby, L. K., Sulmasy, D. P., Barst, R. J., Fair, J. M., Flather, M., Freedman, J. E., Frye, R. L., Hand, M. M., Jesse, R. L., Van de Werf, F., Costa, F. (2004). The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting. Circulation 109: 2672-2679 [Abstract] [Full Text]  
• de Groot, J. R, Coronel, R. (2004). Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis. Cardiovasc Res 62: 323-334 [Abstract] [Full Text]  
• Wever, E. F. D., Robles de Medina, E. O. (2004). Sudden death in patients without structural heart disease. J Am Coll Cardiol 43: 1137-1144 [Abstract] [Full Text]  
• Qu, Z., Karagueuzian, H. S., Garfinkel, A., Weiss, J. N. (2004). Effects of Na+ channel and cell coupling abnormalities on vulnerability to reentry: a simulation study. Am. J. Physiol. Heart Circ. Physiol. 286: H1310-H1321 [Abstract] [Full Text]  
• Prystowsky, E. N. (2004). Primary Prevention of Sudden Cardiac Death: The Time of Your Life. Circulation 109: 1073-1075 [Full Text]  
• Singh, B. N., Wadhani, N. (2004). Antiarrhythmic and Proarrhythmic Properties of QT-Prolonging Antianginal Drugs. J CARDIOVASC PHARMACOL THER 9: S85-S97 [Abstract]  
• Hirsch, L. (2004). Randomized clinical trials: What gets published, and when?. CMAJ 170: 481-483 [Full Text]